Method and formulation for treating CNS disorders
AssigneeSchering Corporation
InventorVicki L. Coffin
Life of this patent
Estimating the term…
Abstract
A method for treating CNS disorders and/or improving cognitive ability in a mammal utilizing 2-phenyl-1,3-propanediol monocarbamate is disclosed. Also disclosed are formulations and methods for manufacturing this compound.
Claims7
A method for treating a CNS disorder selected from the class consisting of SDAT, age-associated memory impairment, major affective disorders, neurotic disorders and psychotic disorders in a mammal in need of said treatment comprising administering to said mammal a CNS effective amount of 2-phenyl-1,3-propanediol monocarbamate.
A pharmaceutical composition comprising 2-phenyl-1,3-propanediol monocarbamate in combination with a pharmaceutically acceptable carrier.
A method for preparing a pharmaceutical composition comprising admixing 2-phenyl-1,3-propanediol monocarbamate with a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.